Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 558141 - 558160 out of 558182 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EM03) alpelisib (adm: O) | PIQRAY 200MGX14/50MGX14 (250MG) TAB,ORAL PKT | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG + 200MG TAB | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Genetic Diseases, Inborn;Growth Disorders | NovartisPharmaceuticalsCorporation |
| USA | (L01EM03) alpelisib (adm: O) | VIJOICE 50MG + 200MG TAB | 2X28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Genetic Diseases, Inborn;Growth Disorders | NovartisPharmaceuticalsCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 13.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 13.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 4.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 4.5MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 9MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EN02) pemigatinib (adm: O) | PEMAZYRE 9MG TAB | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
Cholangiocarcinoma | IncyteCorporation |
| USA | (L01EP01) capmatinib (adm: O) | TABRECTA 150MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EP01) capmatinib (adm: O) | TABRECTA 150MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EP01) capmatinib (adm: O) | TABRECTA 200MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EP01) capmatinib (adm: O) | TABRECTA 200MG TAB | 56 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NovartisPharmaceuticalsCorporation |
| USA | (L01EX) other protein kinase inhibitors | ENCELTO IMPLANT,OPH | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | NeurotechPharmaceuticals,Inc.d/b/aNeurotechUSACorp |
| USA | (L01EX02) sorafenib (adm: O) | NEXAVAR 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX02) sorafenib (adm: O) | NEXAVAR 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX02) sorafenib (adm: O) | NEXAVAR 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX02) sorafenib (adm: O) | NEXAVAR 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Hepatocellular;Carcinoma, Renal Cell | BayerHealthCarePharmaceuticals,Inc. |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
| USA | (L01EX03) pazopanib (adm: O) | VOTRIENT 200MG TAB | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Renal Cell | NovartisPharmaceuticalsCorporation |
Pages
